Future Oncology Journal Issues Research Articles in Vol. 17, No. 30
October 20, 2021
October 20, 2021
LONDON, England, Oct. 20 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in its Vol. 17, No. 30 edition:
Research Articles:
* Real-world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA
* Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma
< . . .
Research Articles:
* Real-world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA
* Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma
< . . .